Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Alemtuzumab +3 More for Sickle Cell Disease
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial aims to find out if giving daratumumab before a certain type of transplant can prevent a specific blood disorder in patients with certain antibodies. The goal is to have similar success and safety levels
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.